Skip to content
Wenlo
Sign in
← Markets
Market open · Closes 4:00 PM ET

VTRS Viatris Inc.

NASDAQ
$19.04−$0.17 (−0.86%)

As of 3:59:00 PM ET · 2 days old

Loading chart…

Open
$19.29
Previous close
$19.20
Day range
19.00 – 19.51
52-week range
9.92 – 19.51
Volume
8.8M
Avg volume (3M)
9.1M
Market cap
$21.9B
P/E (TTM)
235.80
EPS (TTM)
−$0.36
Beta
0.86
Dividend yield
2.52%
Next earnings
—
Ex-dividend
Aug 21, 2026
Sector
Healthcare

About Viatris Inc.

Viatris Inc. is a global healthcare company that develops, manufactures, and markets prescription medicines across a broad range of therapeutic areas. Its portfolio includes branded medicines, generic drugs, complex generics, and biosimilars, serving patients and healthcare providers in developed and emerging markets. The company also supplies active pharmaceutical ingredients used in pharmaceutical manufacturing and supports access to medicines through broad commercial and distribution capabilities. Viatris Inc. operates across regions including North America, Europe, Greater China, Japan, Australia, New Zealand, Latin America, Africa, and the Middle East. Its products address conditions in areas such as cardiovascular health, infectious diseases, central nervous system disorders, immunology, and oncology. By combining established brands with off-patent and technically complex medicines, Viatris Inc. occupies an important role in the global pharmaceutical market, helping manufacturers, healthcare systems, and patients access a wide range of essential treatments.

VTRS news and filings

Loading filings…

Filings from SEC EDGAR.